Form D Explorer

Form D — Sparrow Pharmaceuticals, Inc.

0001786949-25-000002 · filed Jul 1, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
06b
Reported offering amount
$121,400,027
Reported amount sold
$61,841,225
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Sparrow Pharmaceuticals, Inc.
CIK
1786949
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
1050 Southwest 6th Street
PORTLAND, OR 97204
Phone
6174650328

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗